Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, cash reserves at SynAct Pharma AB fell by 45.85m. Cash Flow from Financing totalled 53.98m or -- of revenues. In addition the company used 100.18m for operations while cash from investing totalled 370.00k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.53 |
---|---|
Tangible book value per share | 0.9024 |
More ▼
Balance sheet in SEKView more
Current ratio | 4.25 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0077 |
---|---|
Total debt/total capital | 0.0076 |
More ▼